rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    GOVX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      GeoVax Labs enacts 1-for-24 reverse stock split on Nasdaq Capital Market
      Nov 12Investing.comGOVX
      GeoVax Labs appoints new director and interim CEO following board changes
      Nov 9Investing.comGOVX
      GeoVax Announces 1-for-24 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement
      Nov 9Yahoo FinanceGOVX
      GeoVax Labs terminates CEO David A. Dodd for cause, retains board chair role
      Nov 6Investing.comGOVX
      GeoVax Enters Into $1 Million Revolving Loan Agreement
      Oct 26Yahoo FinanceGOVX
      GeoVax to Highlight Next-Generation MVA Vaccine and Manufacturing Advances at World Vaccine Congress Europe 2026

      Presentation to Highlight Single-Dose MVA and Continuous Cell-Line MVA Manufacturing Innovations ATLANTA, GA - October 6, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunothe...

      Oct 6Yahoo FinanceGOVX
      GeoVax Highlights Likely Sustained Clade Ib Mpox Transmission in the United States
      Sep 29Yahoo FinanceGOVX
      GeoVax Next-Generation MVA Vaccine Demonstrates Durable Single-Dose Protection in Preclinical Models

      Study Shows Protection Against Highly Pathogenic Clade I Mpox Virus and Durable CD8+ T-Cell Responses Findings Support GeoVax's Broader Strategy to Expand the Utility of the MVA Vaccine Platform ATLANTA, GA - September 21, 2026 (NEWMEDIAWIRE) - GeoVa...

      Sep 21Yahoo FinanceGOVX
      12 Health Care Stocks Moving In Friday's After-Market Session
      Sep 18BenzingaGOVX
      GeoVax Confirms Bundibugyo Ebola Vaccine Construct

      BDBV-Specific Construct Developed Using GeoVax Proprietary Rapid Cloning Technology and Builds on Established Filovirus Vaccine Experience GEO-MVA (Mpox/Smallpox Vaccine) Targeted for Phase 3 Initiation Remains Company Priority ATLANTA, GA - Septembe...

      Sep 16Yahoo FinanceGOVX
      GeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 Trial

      Independent Evaluation Supports GEO-MVA Pivotal Phase 3 Program Advances GeoVax's Strategy to Expand and Diversify MVA Vaccine Supply ATLANTA, GA - September 14, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology c...

      Sep 14Yahoo FinanceGOVX
      GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

      Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

      Sep 11The Globe and MailGOVX
      GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities

      ATLANTA, GA - September 10, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against high-consequence infectious diseases and solid tumor cancers, today provided an...

      Sep 10Yahoo FinanceGOVX
      GeoVax Welcomes Launch of Global Mpox Vaccine Stockpile, Highlights GEO-MVA Readiness to Support Diversified Global Supply

      Gavi-funded, ICG-Coordinated Initiative Establishes Long-Term Infrastructure for Timely and Equitable Mpox Vaccine Access During Outbreaks New Stockpile Framework Supports Sustainable Supply and Long-Term Global Preparedness ATLANTA, GA - September 9...

      Sep 9Yahoo FinanceGOVX
      GeoVax Labs Faces Nasdaq Delisting, Plans Appeal Hearing

      Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

      Aug 29The Globe and MailGOVX
      GeoVax Announces a Warrant Inducement Transaction

      ATLANTA, GA - August 26, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies, today announced its entry into a warrant inducement agreement with an existing institutio...

      Aug 26Yahoo FinanceGOVX
      GeoVax Advances GEO-MVA Toward Pivotal Phase 3 Study Implementation

      Selections of CRO and European Clinical Sites Represent Significant Milestones Toward Initiation of the GEO-MVA Immunobridging Study ATLANTA, GA - August 25, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology compa...

      Aug 25Yahoo FinanceGOVX
      GeoVax Initiates Global Health Outreach to WHO, Africa CDC and Other Agencies Regarding Ebola Vaccine Portfolio Amid Expanding Outbreak

      Emerging Evidence of Potential Protection From Authorized Ebola Zaire Vaccine Against Bundibugyo Virus Provides Rationale for Evaluating GeoVax's MVA-Based Ebola Vaccine Candidates ATLANTA, GA - August 24, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nas...

      Aug 24Yahoo FinanceGOVX
      GeoVax Applauds Clinical Validation of Combination Immunotherapy Strategies

      Moderna-Merck Positive Phase 3 Combination Results Reinforce Strategic Rationale for Planned Gedeptin(R) + KEYTRUDA(R) Study ATLANTA, GA - August 24, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company devel...

      Aug 24Yahoo FinanceGOVX

      This is the newest page. Registered accounts read further back.